Inhibits IL-7 Α Soluble IL-7R

Total Page:16

File Type:pdf, Size:1020Kb

Inhibits IL-7 Α Soluble IL-7R Soluble IL-7Rα (sCD127) Inhibits IL-7 Activity and Is Increased in HIV Infection Angela M. Crawley, Sylvie Faucher and Jonathan B. Angel This information is current as J Immunol 2010; 184:4679-4687; Prepublished online 19 of September 25, 2021. March 2010; doi: 10.4049/jimmunol.0903758 http://www.jimmunol.org/content/184/9/4679 Downloaded from References This article cites 51 articles, 19 of which you can access for free at: http://www.jimmunol.org/content/184/9/4679.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 25, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2010 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Soluble IL-7Ra (sCD127) Inhibits IL-7 Activity and Is Increased in HIV Infection Angela M. Crawley,*,† Sylvie Faucher,‡ and Jonathan B. Angel*,†,x Soluble CD127 (sCD127) appears to play an important role in the immunopathogenesis of several chronic infections, multiple scle- rosis, and various cancers. The function of sCD127 and whether it influences IL-7 bioavailability or activity is unknown. In this study, we demonstrated that recombinant and native sources of sCD127 significantly inhibited IL-7–mediated STAT5 and Akt phosphorylation in CD8+ T cells. IL-7–mediated proliferation and Bcl-2 expression were similarly reduced by sCD127. In each case, native sCD127 inhibited IL-7 activity to a greater degree than rsCD127. Anti–IL-7 activity was inherent to human plasma and could be reversed by depletion of CD127, revealing for the first time the biological activity of naturally occurring sCD127. Plasma sCD127 concentrations were increased in HIV+ individuals compared with HIV2 controls, correlated with IL-7 levels, and + remained unchanged in HIV individuals following 1 y of effective antiretroviral therapy. Determining the regulation and function Downloaded from of sCD127 may be critical for understanding both the pathogenesis of diseases in which IL-7 likely has a role (e.g., HIV infection, cancer) and its potential impact on IL-7 as a therapeutic approach. The Journal of Immunology, 2010, 184: 4679–4687. t has recently been suggested that soluble CD127 (sCD127) modulating activity of their cytokine ligands, soluble cytokine plays a role in the immunopathogenesis of several diseases receptors have been shown to be of prognostic value in a number I such as multiple sclerosis (MS), acute lymphoblastic leuke- of diseases and have also been developed as therapeutic agents in http://www.jimmunol.org/ mia, and HIV infection (1–3). Genetic evidence has revealed an the treatment of a number of inflammatory diseases (5). To date, association between soluble isoforms of CD127 and chronic a number of soluble cytokine receptors have been identified, and progressive MS, and increased levels of sCD127 transcripts have their mechanisms of release, unique functions, and putative been documented in children with acute lymphoblastic leukemia. pathophysiological roles have been described (4, 5). The first In HIV infection, individuals lacking HIV-specific cytotoxic ac- identified soluble cytokine receptor was IL-2Ra (sIL-2Ra), and it tivity have increased concentrations of sCD127 (3). Although has been associated with leukemia disease progression and is increased levels of sCD127 have been detected in a number of a marker of poor prognosis in children with Hodgkin’s disease (6). disease states and have been associated with disease activity, the The IL-2Ra gene region, a known autoimmune susceptibility lo- biological function of sCD127 and its clinical relevance remains cus, possesses significant allelic heterogeneity related to either by guest on September 25, 2021 to be established. susceptibility and risk to MS and type 1 diabetes, and these allelic Soluble cytokine receptors have the ability to influence the variants independently correlate with plasma sIL-2Ra concen- extracellular bioavailability of their ligand and have been shown to trations (7). Antagonistic soluble receptors including TNFR I and play important roles in several aspects of the immune response II can inhibit TNF signaling and have been shown to prevent TNF- including inflammation, cellular proliferation, and apoptosis. In mediated tumor lysis (8). The IL-6R subunit gp130 has also been many cases, soluble cytokine receptors act as competitive inhib- shown to inhibit the proinflammatory activity of IL-6 (9). sIL- itors, or, alternatively, they can enhance the activity of the cytokine. 15Ra is an example of an agonistic cytokine receptor. Pre- The former effect has led to the idea that the release of soluble complexed IL-15–sIL-15Ra increases NK and CD8+ T cell pro- cytokine receptors is a physiological mechanism for regulating the liferation and antitumor activity up to 50 times compared with IL- activity of cytokines, as production of the soluble receptor often 15 alone (10, 11). parallels synthesis of the ligand (4). In addition to their role in The biological role of sCD127 is not yet known, although it is plausible that sCD127 could bind circulating IL-7, thereby de- creasing IL-7 bioavailability. In HIV infection, there may be causal *Ottawa Hospital Research Institute; †Department of Biochemistry, Microbiology and Immunology, University of Ottawa; ‡National HIV Immunology Laboratory, National links between the increase in plasma IL-7 levels and higher con- HIV and Retrovirology Labs, Centre for Infectious Disease Prevention and Control centrations of sCD127. Therefore, we have investigated the impact x Health Canada; and Division of Infectious Diseases, Ottawa Hospital-General Campus, of sCD127 on IL-7 activity in human CD8+ T cells and quantified Ottawa, Ontario, Canada plasma sCD127 concentration in HIV infection to better un- Received for publication November 23, 2009. Accepted for publication February 20, 2010. derstand its role in immunopathogenesis. This work was supported by Grant ROGB131 from the Ontario HIV Treatment Network (OHTN), Grant HOP84649 from the Canadian Institutes of Health Re- Materials and Methods search, and Canadian Foundation for AIDS Research Grant 019014. A.M.C. is a re- Sample collection and cell isolation cipient of an OHTN fellowship and J.B.A. is an OHTN Career Scientist. Address correspondence and reprint requests to Dr. Jonathan B. Angel, Division of All research conducted using blood from human subjects was approved by Infectious Diseases, Ottawa Hospital-General Campus, 501 Smyth Road, Room the Ottawa Hospital and Ottawa Hospital Research Institute’s Research G-12, Ottawa, ON K1H 8L6, Canada. E-mail address: [email protected] Ethics Board (Ottawa, Ontario, Canada). Plasma was collected from Fi- coll-Paque gradients of heparinized blood from both HIV2 and HIV+ in- Abbreviations used in this paper: MFI, mean fluorescence intensity; MS, multiple 2 + sclerosis; pSTAT5, phosphorylated STAT5; sCD127, soluble CD127; WI-sup, super- dividuals and stored at 80˚C. The HIV individuals studied were natants of WI-26VA4 cell. recruited from the HIV clinic at the Ottawa Hospital. Blood was drawn, and plasma was isolated from individuals either naive to antiretroviral Copyright Ó 2010 by The American Association of Immunologists, Inc. 0022-1767/10/$16.00 therapy or off antiretroviral therapy for .6 mo at the time of sampling. www.jimmunol.org/cgi/doi/10.4049/jimmunol.0903758 4680 ROLE OF SOLUBLE IL-7Ra IN IL-7 ACTIVITY AND HIV Plasma from an additional 14 HIV+ individuals was obtained in the context of Buckinghamshire, U.K.). Densitometry analysis of protein bands was a previously reported clinical trial of highly active antiretroviral therapy (12). performed using AlphaEase Fc Software 6.0 (a Innotech, San Leandro, For in vitro tissue culture experiments, PBMCs from healthy HIV seroneg- CA), and relative changes in protein expression of treated cells were cal- ative volunteers were isolated by Ficoll-Paque PLUS (Pharmacia Fine culated compared with unstimulated controls. Chemicals, Piscataway, NJ) gradient separation, washed twice in PBS, and resuspended in RPMI medium 1640 supplemented with penicillin-strepto- Bcl-2 expression mycin and 10% FCS at a concentration of 1 3 106 cells/ml. Isolation of CD8+ After 48 h of culture, intracellular Bcl-2 staining was performed using the T cells from PBMCs was conducted using a MACS CD8+ T Cell Isolation kit BD Biosciences FITC-conjugated Bcl-2 Ab reagent set, following the (Miltenyi Biotec, Auburn, CA) in accordance with the manufacturer’s in- manufacturer’s protocol (BD Biosciences). Cells were washed with PBS structions, achieving a purity of .98–99% as verified by flow cytometry. and resuspended in fixation buffer (100 ml/1 3 105 cells; eBioscience, San Purified CD8+ T cells were resuspended at 106 cells/ml in RPMI 1640 sup- Diego, CA) and incubated at room temperature for 20 min. Following plemented with penicillin-streptomycin and 20% FCS. incubation, cells were washed, resuspended in permeabilization buffer (100 ml/105 cells) with FITC-conjugated Bcl-2 Ab (2 ml/1 3 105 cells; BD IL-7 and IL-7R reagents Biosciences), and incubated at room temperature for 20 min. Samples were 5 Recombinant human IL-7 (Sigma-Aldrich, Oakville, Ontario, Canada), washed and then resuspended in flow staining buffer (0.5 ml/1 3 10 cells; a lyophilized product, was resuspended in PBS at a concentration of 10 mg/ eBioscience). Analysis was performed by flow cytometry, collecting ml and stored at 220˚C.
Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0070450 A1 Ishikawa Et Al
    US 20120070450A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0070450 A1 Ishikawa et al. (43) Pub. Date: Mar. 22, 2012 (54) LEUKEMA STEM CELLMARKERS Publication Classification (51) Int. Cl. A 6LX 39/395 (2006.01) (75) Inventors: Fumihiko Ishikawa, Kanagawa CI2O I/68 (2006.01) (JP): Osamu Ohara, Kanagawa GOIN 2L/64 (2006.01) (JP); Yoriko Saito, Kanagawa (JP); A6IP35/02 (2006.01) Hiroshi Kitamura, Kanagawa (JP); C40B 30/04 (2006.01) Atsushi Hijikata, Kanagawa (JP); A63L/7088 (2006.01) Hidetoshi Ozawa, Kanagawa (JP); C07K 6/8 (2006.01) Leonard D. Shultz, Bar Harbor, C7H 2L/00 (2006.01) A6II 35/12 (2006.01) ME (US) CI2N 5/078 (2010.01) (52) U.S. Cl. .................. 424/173.1; 424/178.1; 424/93.7: (73) Assignee: RIKEN, Wako-shi (JP) 435/6.14; 435/723; 435/375; 506/9: 514/44 A: 530/389.6; 530/391.7:536/24.5 (57) ABSTRACT (21) Appl. No.: 13/258,993 The invention provides a test method for predicting the initial onset or a recurrence of acute myeloid leukemia (AML) com PCT Fled: prising (1) measuring the expression level of human leukemic (22) Mar. 24, 2010 stem cell (LSC) marker genes in a biological sample collected from a Subject for a transcription product or translation prod uct of the gene as an analyte and (2) comparing the expression (86) PCT NO.: PCT/UP2010/0551.31 level with a reference value; an LSC-targeting therapeutic agent for AML capable of Suppressing the expression of a S371 (c)(1), gene selected from among LSC marker genes or a Substance (2), (4) Date: Dec.
    [Show full text]
  • Contribution of IL9, IL2RA and IL2RB Genetic Polymorphisms in Coronary Heart Disease in Chinese Han Population
    Contribution of IL9, IL2RA and IL2RB genetic polymorphisms in coronary heart disease in Chinese Han population Xianghong Chen The Second Aliated Hospital of Hainan Medical University Xingfan Wang The Second Aliated Hospital of Hainan Medical University Zaozhang q Zhang The second Aliated Hospital of Hainan Medical University Yuewu Chen The Second Aliated Hospital of Hainan Medical University Chao Wang ( [email protected] ) The Second Aliated Hospital of Hainan Medical Universiy https://orcid.org/0000-0001-5632-9778 Research article Keywords: Posted Date: December 9th, 2019 DOI: https://doi.org/10.21203/rs.2.18401/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/11 Abstract Background: Coronary heart disease (CHD) is one of the leading causes of disability and death worldwide. In the pathogenesis of CHD, inammatory cytokines take an essential part. This study was designed to detect the potential association between IL-9, IL-2RA and IL-2RB variants and CHD in Chinese Han population. Methods: This case-control study conducted 499 CHD patients and 496 healthy controls. Seven selected SNPs were genotyped to investigate the possible association between the polymorphisms and the CHD risk. The interaction of SNP-SNP in the CHD risk was analyzed by Multifactor dimensionality reduction (MDR). Results: We observed an association between IL-9 rs55692658 (OR = 1.72, p = 0.003) and the increased CHD risk. The stratication analysis by age indicated that no matter participants who were older or younger than 61 years, IL-9 rs55692658 and IL-2RB rs1573673 contributed to the CHD susceptibility signicantly (p < 0.05, respectively).
    [Show full text]
  • An Ontogenetic Switch Drives the Positive and Negative Selection of B Cells
    An ontogenetic switch drives the positive and negative selection of B cells Xijin Xua, Mukta Deobagkar-Lelea, Katherine R. Bulla, Tanya L. Crockforda, Adam J. Meadb, Adam P. Cribbsc, David Simsc, Consuelo Anzilottia, and Richard J. Cornalla,1 aMedical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, OX3 9DS Oxford, United Kingdom; bMedical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, OX3 9DS Oxford, United Kingdom; and cMedical Research Council, Weatherall Institute of Molecular Medicine, Centre for Computational Biology, Weatherall Institute of Molecular Medicine, University of Oxford, OX3 9DS Oxford, United Kingdom Edited by Michael Reth, University of Freiburg, Freiburg, Germany, and approved January 6, 2020 (received for review September 3, 2019) + Developing B cells can be positively or negatively selected by self- BM HSCs increased CD5 B-1a B cell development (15), while antigens, but the mechanisms that determine these outcomes are expression of let-7b in FL pro-B cells blocked the development of incompletely understood. Here, we show that a B cell intrinsic B-1 B cells (17). These findings support the notion of hard-wired switch between positive and negative selection during ontogeny differences during ontogeny, but possibly downstream of the HSC is determined by a change from Lin28b to let-7 gene expression. commitment stage. Ectopic expression of a Lin28b transgene in murine B cells restored Several lines of evidence also suggest that B-1 B cells can un- the positive selection of autoreactive B-1 B cells by self-antigen in dergo positive selection, which is linked to their B cell receptor adult bone marrow.
    [Show full text]
  • Tethering IL2 to Its Receptor Il2rb Enhances Antitumor Activity and Expansion of Natural Killer NK92 Cells Youssef Jounaidi, Joseph F
    Published OnlineFirst September 15, 2017; DOI: 10.1158/0008-5472.CAN-17-1007 Cancer Therapeutics, Targets, and Chemical Biology Research Tethering IL2 to Its Receptor IL2Rb Enhances Antitumor Activity and Expansion of Natural Killer NK92 Cells Youssef Jounaidi, Joseph F. Cotten, Keith W. Miller, and Stuart A. Forman Abstract IL2 is an immunostimulatory cytokine for key immune cells of IL2 and its receptor IL2Rb joined via a peptide linker (CIRB). including T cells and natural killer (NK) cells. Systemic IL2 NK92 cells expressing CIRB (NK92CIRB) were highly activated and supplementation could enhance NK-mediated immunity in a expanded indefinitely without exogenous IL2. When compared variety of diseases ranging from neoplasms to viral infection. with an IL2-secreting NK92 cell line, NK92CIRB were more acti- However, its systemic use is restricted by its serious side effects and vated, cytotoxic, and resistant to growth inhibition. Direct contact limited efficacy due to activation of T regulatory cells (Tregs). IL2 with cancer cells enhanced the cytotoxic character of NK92CIRB signaling is mediated through interactions with a multi-subunit cells, which displayed superior in vivo antitumor effects in mice. receptor complex containing IL2Ra, IL2Rb, and IL2Rg. Adult Overall, our results showed how tethering IL2 to its receptor natural killer (NK) cells express only IL2Rb and IL2Rg subunits IL2Rb eliminates the need for IL2Ra and IL2Rb, offering a and are therefore relatively insensitive to IL2. To overcome these new tool to selectively activate and empower immune therapy. limitations, we created a novel chimeric IL2-IL2Rb fusion protein Cancer Res; 77(21); 5938–51. Ó2017 AACR. Introduction in order for allogeneic NK cells to be effective, pretransfer lymphodepletion is required to reduce competition for growth Natural killer (NK) cells are lymphocytes endowed with the factors and cytokines (14, 15).
    [Show full text]
  • Evaluation of the IL2/IL21, IL2RA and IL2RB Genetic Variants Influence On
    Cénit et al. BMC Medical Genetics 2013, 14:52 http://www.biomedcentral.com/1471-2350/14/52 RESEARCH ARTICLE Open Access Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition María Carmen Cénit1*†, Ana Márquez1†, Miguel Cordero-Coma2, Alejandro Fonollosa3, Alfredo Adán4, Agustín Martínez-Berriotxoa3, Victor Llorenç4, David Díaz Valle5, Ricardo Blanco6, Joaquín Cañal7, Manuel Díaz-Llopis8, José Luis García Serrano9, Enrique de Ramón10, María José del Rio11, Marina Begoña Gorroño- Echebarría12, José Manuel Martín-Villa13, Norberto Ortego-Centeno14 and Javier Martín1 Abstract Background: Recently, different genetic variants located within the IL2/IL21 genetic region as well as within both IL2RA and IL2RB loci have been associated to multiple autoimmune disorders. We aimed to investigate for the first time the potential influence of the IL2/IL21, IL2RA and IL2RB most associated polymorphisms with autoimmunity on the endogenous non-anterior uveitis genetic predisposition. Methods: A total of 196 patients with endogenous non-anterior uveitis and 760 healthy controls, all of them from Caucasian population, were included in the current study. The IL2/IL21 (rs2069762, rs6822844 and rs907715), IL2RA (2104286, rs11594656 and rs12722495) and IL2RB (rs743777) genetic variants were genotyped using TaqMan® allelic discrimination assays. Results: A statistically significant difference was found for the rs6822844 (IL2/IL21 region) minor allele frequency in the group of uveitis patients compared with controls (P-value=0.02, OR=0.64 CI 95%=0.43-0.94) although the significance was lost after multiple testing correction. Furthermore, no evidence of association with uveitis was detected for the analyzed genetic variants of the IL2RA or IL2RB loci.
    [Show full text]
  • Identification of Stage-Specific Surface Markers in Early B Cell
    Identification of Stage-Specific Surface Markers in Early B Cell Development Provides Novel Tools for Identification of Progenitor Populations This information is current as of September 28, 2021. Christina T. Jensen, Stefan Lang, Rajesh Somasundaram, Shamit Soneji and Mikael Sigvardsson J Immunol published online 25 July 2016 http://www.jimmunol.org/content/early/2016/07/23/jimmun ol.1600297 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2016/07/23/jimmunol.160029 Material 7.DCSupplemental http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 28, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published July 25, 2016, doi:10.4049/jimmunol.1600297 The Journal of Immunology Identification of Stage-Specific Surface Markers in Early B Cell Development Provides Novel Tools for Identification of Progenitor Populations Christina T. Jensen,* Stefan Lang,* Rajesh Somasundaram,† Shamit Soneji,* and Mikael Sigvardsson*,† Whereas the characterization of B lymphoid progenitors has been facilitated by the identification of lineage- and stage-specific surface markers, the continued identification of differentially expressed proteins increases our capacity to explore normal and malignant B cell development.
    [Show full text]
  • IL2RA and IL7RA Genes Confer Susceptibility for Multiple Sclerosis in Two Independent European Populations
    Genes and Immunity (2008) 9, 259–263 & 2008 Nature Publishing Group All rights reserved 1466-4879/08 $30.00 www.nature.com/gene ORIGINAL ARTICLE IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations F Weber1,10, B Fontaine2,3,4,10, I Cournu-Rebeix2,3,4, A Kroner5, M Knop1, S Lutz1,FMu¨ ller-Sarnowski1, M Uhr1, T Bettecken1, M Kohli1, S Ripke1, M Ising1, P Rieckmann5,11, D Brassat6, G Semana7, M-C Babron8,9, S Mrejen2,3,4, C Gout2,3,4, O Lyon-Caen2,3,4, J Yaouanq7, G Edan7, M Clanet6, F Holsboer1, F Clerget-Darpoux8,9,12 and B Mu¨ ller-Myhsok1,12 1Max Planck Institute of Psychiatry, Munich, Germany; 2Fe´de´ration des Maladies du Syste`me Nerveux, Assistance Publique-Hoˆpitaux de Paris, G.H. Pitie´-Salpeˆtrie`re, Paris, France; 3UMR546, INSERM, Paris, France; 4UMR S546, University Pierre et Marie Curie-Paris 6, Paris, France; 5Department of Neurology, University of Wu¨rzburg, Wu¨rzburg, Germany; 6Fe´de´ration de Neurologie, University of Toulouse, Toulouse, France; 7Department of Neurology, CHU Pontchaillou, Rennes, France; 8U535, INSERM, Villejuif, France and 9UMRS535, Univ Paris Sud, Villejuif, France Multiple sclerosis (MS) is the most common chronic inflammatory neurologic disorder diagnosed in young adults and, due to its chronic course, is responsible for a substantial economic burden. MS is considered to be a multifactorial disease in which both genetic and environmental factors intervene. The well-established human leukocyte antigen (HLA) association does not completely explain the genetic impact on disease susceptibility. However, identification and validation of non-HLA-genes conferring susceptibility to MS has proven to be difficult probably because of the small individual contribution of each of these genes.
    [Show full text]
  • Immune Suppressive Landscape in the Human Esophageal Squamous Cell
    ARTICLE https://doi.org/10.1038/s41467-020-20019-0 OPEN Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment ✉ Yingxia Zheng 1,2,10 , Zheyi Chen1,10, Yichao Han 3,10, Li Han1,10, Xin Zou4, Bingqian Zhou1, Rui Hu5, Jie Hao4, Shihao Bai4, Haibo Xiao5, Wei Vivian Li6, Alex Bueker7, Yanhui Ma1, Guohua Xie1, Junyao Yang1, ✉ ✉ ✉ Shiyu Chen1, Hecheng Li 3 , Jian Cao 7,8 & Lisong Shen 1,9 1234567890():,; Cancer immunotherapy has revolutionized cancer treatment, and it relies heavily on the comprehensive understanding of the immune landscape of the tumor microenvironment (TME). Here, we obtain a detailed immune cell atlas of esophageal squamous cell carcinoma (ESCC) at single-cell resolution. Exhausted T and NK cells, regulatory T cells (Tregs), alternatively activated macrophages and tolerogenic dendritic cells are dominant in the TME. Transcriptional profiling coupled with T cell receptor (TCR) sequencing reveal lineage con- nections in T cell populations. CD8 T cells show continuous progression from pre-exhausted to exhausted T cells. While exhausted CD4, CD8 T and NK cells are major proliferative cell components in the TME, the crosstalk between macrophages and Tregs contributes to potential immunosuppression in the TME. Our results indicate several immunosuppressive mechanisms that may be simultaneously responsible for the failure of immuno-surveillance. Specific targeting of these immunosuppressive pathways may reactivate anti-tumor immune responses in ESCC. 1 Department of Laboratory Medicine, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 2 Institute of Biliary Tract Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 3 Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
    [Show full text]
  • Triangulating Molecular Evidence to Prioritise Candidate Causal Genes at Established Atopic Dermatitis Loci
    medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20240838; this version posted November 30, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license . Triangulating molecular evidence to prioritise candidate causal genes at established atopic dermatitis loci Maria K Sobczyk1, Tom G Richardson1, Verena Zuber2,3, Josine L Min1, eQTLGen Consortium4, BIOS Consortium5, GoDMC, Tom R Gaunt1, Lavinia Paternoster1* 1) MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, UK 2) Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK 3) MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK 4) Members of the eQTLGen Consortium are listed in: Supplementary_Consortium_members.docx 5) Members of the BIOS Consortium are listed in: Supplementary_Consortium_members.docx Abstract Background: Genome-wide association studies for atopic dermatitis (AD, eczema) have identified 25 reproducible loci associated in populations of European descent. We attempt to prioritise candidate causal genes at these loci using a multifaceted bioinformatic approach and extensive molecular resources compiled into a novel pipeline: ADGAPP (Atopic Dermatitis GWAS Annotation & Prioritisation Pipeline). Methods: We identified a comprehensive list of 103 accessible
    [Show full text]
  • Single Cell Transcriptomics of Regulatory T Cells Reveals Trajectories of Tissue Adaptation ​ ​ ​ ​ ​ ​
    bioRxiv preprint doi: https://doi.org/10.1101/217489; this version posted November 22, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Single cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation ​ ​ ​ ​ ​ ​ Authors: 1,2,a 1,a 3,4 7 Ricardo J Miragaia ,​ Tomás Gomes ,​ Agnieszka Chomka ,​ Laura Jardine ,​ Angela ​ ​ ​ ​ 8 3,4,5 1,9 1 3,4,6 Riedel ,​ Ahmed N. Hegazy ,​ Ida Lindeman ,​ Guy Emerton ,​ Thomas Krausgruber ,​ ​ ​ ​ ​ ​ 8 7 3,4 1,10,11,* Jacqueline Shields ,​ Muzlifah Haniffa ,​ Fiona Powrie ,​ Sarah A. Teichmann ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Affiliations: 1 Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2 Centre of Biological Engineering, University of Minho, Braga, Portugal ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 3 Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK ​ ​ ​ ​ ​ ​ ​ ​ 4 Translational Gastroenterology Unit, Experimental Medicine Division Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 5 Current affiliation: Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health,
    [Show full text]
  • Correction of Autoimmune IL2RA Mutations in Primary Human T Cells Using Non-Viral Genome Targeting
    bioRxiv preprint doi: https://doi.org/10.1101/183418; this version posted September 6, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Title: Correction of autoimmune IL2RA mutations in primary human T cells using non-viral genome targeting Authors: Theodore L. Roth1,2,3,4,5, Ruby Yu3,4,5, Eric Shifrut3,4,5, Joseph Hiatt1,2,3,4,5, Han Li6,7, Kathrin Schumann3,4,5, Victoria Tobin3,4,5, Andrea M. Ferris8, Jeff Chen9, Jean-Nicolas Schickel9, Laurence Pellerin10, David Carmody11, Gorka Alkorta-Aranburu12, Daniela Del Gaudio12, Min Cho13, Hiroyuki Matsumoto14, Montse Morell15, Ying Mao15, David Nguyen3,4,5, Rolen Quadros16, Channabasavaiah Gurumurthy16, Baz Smith15, Michael Haugwitz15, Stephen H. Hughes8, Jonathan Weissman6,7, Andrew P. May13, Gary Kupfer17, Siri Greeley11, Rosa Bacchetta10, Eric Meffre9, Maria Grazia Roncarolo10, Neil Romberg18, Kevan C. Herold19, Manuel D. Leonetti6,7, Alexander Marson3,4,5,13,20,21 * Affiliations: 1 Medical Scientist Training Program, University of California, San Francisco, CA 94143, USA. 2 Biomedical Sciences Graduate Program, University of California, San Francisco, CA 94143, USA. 3 Department of Microbiology and Immunology, University of California, San Francisco, CA 94143, USA. 4 Diabetes Center, University of California, San Francisco, CA 94143, USA. 5 Innovative Genomics Institute, University of California, Berkeley, CA 94720, USA. 6 Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA. 7 Howard Hughes Medical Institute. 8 HIV Dynamics and Replication Program, Vector Design and Replication Section, National Cancer Institute, Frederick, MD, 21702.
    [Show full text]
  • The Multiple Sclerosis Susceptibility Genes TAGAP and IL2RA Are Regulated by Vitamin D in CD4+ T Cells
    Genes and Immunity (2016) 17, 118–127 OPEN © 2016 Macmillan Publishers Limited All rights reserved 1466-4879/16 www.nature.com/gene ORIGINAL ARTICLE The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells T Berge1, IS Leikfoss1,2,7, IS Brorson1,2,7, SD Bos1,2, CM Page1,2, MW Gustavsen1,2, A Bjølgerud1,2, T Holmøy2,3, EG Celius1, J Damoiseaux4, J Smolders5, HF Harbo1,2 and A Spurkland6 Multiple sclerosis (MS) is an inflammatory, demyelinating disorder of the central nervous system that develops in genetically susceptible individuals. The majority of the MS-associated gene variants are located in genetic regions with importance for T-cell differentiation. Vitamin D is a potent immunomodulator, and vitamin D deficiency has been suggested to be associated with increased MS disease susceptibility and activity. In CD4+ T cells, we have analyzed in vitro vitamin D responsiveness of genes that contain an MS-associated single-nucleotide polymorphism (SNP) and with one or more vitamin D response elements in their regulatory regions. We identify IL2RA and TAGAP as novel vitamin D target genes. The vitamin D response is observed in samples from both MS patients and controls, and is not dependent on the genotype of MS-associated SNPs in the respective genes. Genes and Immunity (2016) 17, 118–127; doi:10.1038/gene.2015.61; published online 14 January 2016 INTRODUCTION located in non-coding regions of the genome.6,8 Interestingly, the Multiple sclerosis (MS) is an inflammatory, demyelinating disorder MS-associated SNPs are enriched in DNase I hypersensitive sites, of the central nervous system leading to various degrees of indicating a functional role in regulation of gene transcription.9 physical and cognitive disability.
    [Show full text]